Silverarc Capital Management LLC Makes New $300,000 Investme

Silverarc Capital Management LLC acquired a new position in shares of Relmada Therapeutics, Inc. (NASDAQ:RLMD – Free Report) in the 3rd quarter, Holdings Channel.com reports. The firm acquired 100,000 shares of the company’s stock, valued at approximately $300,000. Other institutional investors and hedge funds have also recently added to or reduced their stakes in the […]

Related Keywords

Maged Shenouda , Holdings Channel , Tortoise Investment Management , Relmada Therapeutics Inc , Silverarc Capital Management , Nasdaq , Barclays Plc , Bedel Financial Consulting Inc , Securities Exchange Commission , Boothbay Fund Management , Relmada Therapeutics , Free Report , Financial Consulting , Financial Advisors , Fund Management , Investment Management , Exchange Commission , Chuck Ence , Visit Holdingschannel , Relmada Therapeutics Daily , Nasdaq Rlmd , Rlmd , Medical , Sec Filings , 13f , Hedge Fund Holdings , Institutional Investor Holdings ,